RAPT Therapeutics shares dropped more than 60% premarket on Tuesday after the company said regulators have hit pause on two clinical trials of its experimental inflammation drug.
Source: https://www.marketwatch.com/story/rapt- ... topstories
RAPT Therapeutics’ stock plunges as FDA halts two clinical trials
